HIA’s recent comments about the DEA’s extension of telehealth-prescribing flexibilities was included in an article examining the differing views by Telehealth.org.
HIA’s stance calling to make the policy permanent was an outlier among other groups who took a more conservative approach.
“… the Health Innovation Alliance offers a contrasting view. They assert that the DEA Telehealth Flexibilities, while beneficial, are still too transient. They urge the DEA to acknowledge the success of e-prescribing and to authorize it to move forward fully.”